JPH0518837B2 - - Google Patents

Info

Publication number
JPH0518837B2
JPH0518837B2 JP59024557A JP2455784A JPH0518837B2 JP H0518837 B2 JPH0518837 B2 JP H0518837B2 JP 59024557 A JP59024557 A JP 59024557A JP 2455784 A JP2455784 A JP 2455784A JP H0518837 B2 JPH0518837 B2 JP H0518837B2
Authority
JP
Japan
Prior art keywords
formula
hydroxy
methyl
estradiene
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59024557A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59157099A (ja
Inventor
Neefu Gyuntaa
Zauaa Geruharuto
Uiihieruto Rudorufu
Hoofumaisutaa Herumuuto
Roode Rarufu
Anen Kurausu
Raurento Henrii
Baiaa Jiibire
Rozeruto Uorufugangu
Erugaa Uarutaa
Hendaason Deiuitsuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS59157099A publication Critical patent/JPS59157099A/ja
Priority to US06/697,526 priority Critical patent/US4639148A/en
Publication of JPH0518837B2 publication Critical patent/JPH0518837B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59024557A 1983-02-18 1984-02-14 １１β―アリール―エストラジエン及びその製法 Granted JPS59157099A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/697,526 US4639148A (en) 1984-02-14 1985-02-01 Thrust bearing for turbocharger

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3306121.1 1983-02-18
DE3306121A DE3306121A1 (de) 1983-02-18 1983-02-18 11ss-aryl-spirolaktone in der steroidreihe, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate
DE3306124.6 1983-02-18

Publications (2)

Publication Number Publication Date
JPS59157099A JPS59157099A (ja) 1984-09-06
JPH0518837B2 true JPH0518837B2 (en, 2012) 1993-03-15

Family

ID=6191512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59024557A Granted JPS59157099A (ja) 1983-02-18 1984-02-14 １１β―アリール―エストラジエン及びその製法

Country Status (2)

Country Link
JP (1) JPS59157099A (en, 2012)
DE (1) DE3306121A1 (en, 2012)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438500C1 (de) * 1984-10-18 1986-05-28 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung 11ß-substituierter Δ↑9↑-19-Norsteroide
DE3506785A1 (de) * 1985-02-22 1986-08-28 Schering AG, Berlin und Bergkamen, 1000 Berlin 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) * 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
DE3306121A1 (de) 1984-09-06
JPS59157099A (ja) 1984-09-06

Similar Documents

Publication Publication Date Title
US4536401A (en) 11β-aryl estradienes, processes for their production and pharmaceutical preparations containing them
JPH0559918B2 (en, 2012)
US4814327A (en) 11 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
JP2956776B2 (ja) １３―アルキル―１１β―フエニルゴナン
AU742834B2 (en) Antigestagenic steroids with a fluorinated 17alpha-alkyl chain
JP2588267B2 (ja) １９，１１β―架橋ステロイド，その製造法および該化合物を含有する製薬学的調剤
JP2652007B2 (ja) 位置１７にスピロ環を有する新規なステロイドの製造用中間体
JP3462515B2 (ja) １７−スピロフラン−３′−イリデンステロイド
IE58149B1 (en) 11 beta-phenyl-gonanes,their manufacture and pharmaceutical preparations containing them
US5843933A (en) 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
JP3814312B2 (ja) １１，２１−ビスフェニル−１９−ノルプレグナン誘導体
JPH0443077B2 (en, 2012)
AU2012286648A1 (en) Progesterone antagonists
US5132299A (en) 11β-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same
JPH0437080B2 (en, 2012)
JPS6041695A (ja) １３α−アルキルゴナン、その製造方法及び該化合物を含有する、抗ゲスタ−ゲン作用を有する製剤製品
JPH0518837B2 (en, 2012)
GB2104899A (en) New 17oc-(alkanoyloxyhydrocarbyl)-17b-hydroxy steroids with sebum-suppressive activity
JPH0649717B2 (ja) 二重結合又は三重結合を含む基で１０位置が置換された新規なステロイド、それらの製造法及び薬剤
JP3135564B2 (ja) １１β―置換１６α，１７α―メチレン―エストラ―４，９―ジエン―３―オン
JP2999258B2 (ja) １０β―Ｈ―ステロイドの製法
JP2980389B2 (ja) １７位置にスピロ基を含む新規なステロイド化合物、それらの製造方法及び製造中間体、それらの薬剤としての使用並びにそれらを含有する製薬組成物
FI110688B (fi) 11 beta-aryyli-4-estreenejä ja menetelmä niiden valmistamiseksi
US3997574A (en) 9-α-methyl-steroids
MXPA99007057A (es) Esteroides con actividad antigestagena que tienen una cadena fluorada de 17-alfa-alquilo